https://www.statnews.com/2020/05/04/without-showing-any-data-cytodyn-touts-treatment-for-covid-19-as-winner-while-its-ceo-sells-stock/?utm_source=STAT+Newsletters&utm_campaign=5dea83b99e-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-5dea83b99e-149692869

STAT Plus: Without showing any data, CytoDyn touts treatment for Covid-19 as winner — while its CEO sells stock

By ADAM FEUERSTEIN

CEO Nader Pourhassan plans to sell more than half of his ownership stake in CytoDyn, even as he touts the potential of oone of its drugs to treat Covid-19.

READ MORE